Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Treatments for multiple sclerosis (MS) can control relapses, but don’t stop the disease from progressing—or promote brain repair. But with financial support from the National Multiple Sclerosis ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Mendelian randomization analysis links pork consumption, higher BMI, and T2DM to increased MS risk, while MVPA offers protective benefits. Univariable and multivariable MR analyses confirm causal ...

A new study reveals that following a Mediterranean diet significantly reduces the risk of developing multiple sclerosis. This ...

A team of scientists from The New York Stem Cell Foundation (NYSCF) Research Institute and Case Western Reserve University has created the largest reported collection of stem cell models from multiple ...

New research reveals that when gut bacteria closely resemble the myelin sheath that protects nerve fibers, the immune system can become confused and attack both — accelerating multiple sclerosis.

Studies in recent years have clearly shown that genetic risk variants are a necessary condition for developing multiple sclerosis. "Based on our study, we were able to show that about half of the ...